SEC Form EFFECT filed by SRX Health Solutions Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 15, 2025 3:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 15, 2025 3:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
NORTH PALM BEACH, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), which recently announced a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), today announced that EMJX is enhancing its Gen2 digital-asset treasury operating system through the integration of OpenAI's latest-generation large language models (LLMs) to support internal research workflows and risk-management decision support. EMJX is a digital-asset treasury operating system that applies quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. The platform is led by Eric M. Jackson and is built to manag
DENVER, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions (NYSE:SRXH): A Strategic Pivot Toward Gen2 Digital Treasuries SRx Health Solutions (NYSE:SRXH) headlines the morning with a definitive agreement to acquire EMJ Crypto Technologies (EMJX), marking a transformative shift from traditional healthcare operations toward a next-generation digital-asset treasury platform. The transaction positions SRXH at the intersection of public-market governance and quantitative, AI-enabled treasury management, with closing expected in the first quarter of 2026 pending shareholder approval. Until then, shares will continue trading under the SRXH ticker, with the combined company planning to oper
NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company. A Gen2 Approach to Digital Asset Treasuries:EMJX is designed as a next-generation
424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)
8-K - SRx Health Solutions, Inc. (0001471727) (Filer)
EFFECT - SRx Health Solutions, Inc. (0001471727) (Filer)
4 - SRx Health Solutions, Inc. (0001471727) (Issuer)
3 - SRx Health Solutions, Inc. (0001471727) (Issuer)
3 - SRx Health Solutions, Inc. (0001471727) (Issuer)
TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current
TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port
TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast: https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will